FindTrial
Sign In

Intravenous Dexmedetomidine versus Nebulized Dexmedetomidine for Procedural Sedation during ERCP : A comparative evaluation of sedation efficacy

Intravenous Dexmedetomidine versus Nebulized Dexmedetomidine in Combination with standardized Propofol-Fentanyl-Midazolam for Procedural Sedation during ERCP : A comparative evaluation of sedation efficacy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077496
Enrollment
140
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K803- Calculus of bile duct with cholangitis Health Condition 2: K803- Calculus of bile duct with cholangitis Health Condition 3: K805- Calculus of bile duct without cholangitis or cholecystitis Health Condition 4: K806- Calculus of gallbladder and bile duct with cholecystitis Health Condition 5: K80-K87- Disorders of gallbladder, biliary tract and pancreas

Interventions

Intervention1: nebulized dexmedetomidine: iv dexmedetomidine versus nebulized dexmedetomidine in endoscopic retrograde pancreaticochalangiography procedure under sedation Control Intervention1: nebuli

Sponsors

roushan patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing elective/emergency ERCP procedure under sedation Age between 18-65 years ASA grades I-III

Exclusion criteria

Exclusion criteria: Patients refusing to participate in the study known allergy to any drug used in this study, heart rate of fewer than 50 beats/min, treated with beta-blockers, patient in shock oxygen saturation measured by pulse oximetry (SpO2) less than 90%, left ventricular ejection fraction of less than 50%, kidney or hepatic insufficiency. second- or third-degree heart block, body mass index (BMI) over 36 kg/m2 and

Design outcomes

Primary

MeasureTime frame
To compare the sedation efficacy of intravenous (IV) dexmedetomidine versus nebulized dexmedetomidine in combination with standard propofol-fentanyl-midazolam for procedural sedation during ERCP. Timepoint: The oucome will be assessed at baseline just after the procedure—

Secondary

MeasureTime frame
Assess the safety profile of IV dexmedetomidine versus nebulized dexmedetomidine when administered alongside standard sedation agents. Evaluate patient satisfaction levels with sedation methods involving IV dexmedetomidine and nebulized dexmedetomidine during ERCP procedures. Compare the hemodynamic stability of patients receiving IV dexmedetomidine versus nebulized dexmedetomidine during ERCP sedation.. Timepoint: at the end of surgery—

Countries

India

Contacts

Public ContactRoushan Patel

TATA MAIN HOSPITAL JAMSHEDPUR

Pateljipmer@gmail.com07903728527

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026